Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]
Tremlett, Helen L
7 records totalling $4,002,603.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| Canadian Institutes of Health Research | $4,002,603 | 7 records |
Records
Prescription Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]: a population-based, multi-province platform for comprehensive pharmacovigilance
Canada Research Chair Tier 2
The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...
The Children of Multiple Sclerosis: Impact of chronic disease in parents on early childhood development
Human immunodeficiency virus, antiretroviral drugs and multiple sclerosis risk (HIV-MS)
The BeAMS-50plus Study Benefits and Adverse Effects of Beta-interferon for Multiple Sclerosis patients aged 50 plus